Skip to main content
SpringerLink
Log in

Risk minimisation measures for fentanyl buccal tablets

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. adult patients (18 years of age or older) treated for cancer breakthrough pain who were opioid-tolerant at FBT treatment initiation

Reference

  • Kaplan S, et al. Effectiveness of Risk Minimization Measures for Fentanyl Buccal Tablet (FENTORA) in Canada: A Mixed-Methods Evaluation Using Surveys, Medical Chart Records and Web Surveillance. Drug Safety : 5 Nov 2019. Available from: URL: https://doi.org/10.1007/s40264-019-00882-7

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Risk minimisation measures for fentanyl buccal tablets. Reactions Weekly 1779, 11 (2019). https://doi.org/10.1007/s40278-019-71275-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-71275-y

Search

Navigation